Carregant...
Pharmacogenomics meets precision cardio-oncology: is there synergistic potential?
An individual’s inherited genetic makeup and acquired genomic variants may account for a significant portion of observable variability in therapy efficacy and toxicity. Pharmacogenomics (PGx) is the concept that treatments can be modified to account for these differences to increase chances of thera...
Guardat en:
| Publicat a: | Hum Mol Genet |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7574955/ https://ncbi.nlm.nih.gov/pubmed/32601683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddaa134 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|